Page 4,889«..1020..4,8884,8894,8904,891..4,9004,910..»

At St. Paul hospital, 'Michael J. Fox Show' premiere a reason to gather

Posted: Published on September 25th, 2013

You would probably never think of going to a hospital to watch the premiere of a TV show. But on Thursday, St. Paul's Bethesda Hospital is hosting a viewing party for NBC's new comedy "The Michael J. Fox Show." Sponsored by the hospital's Capistrant Center for Parkinson's Disease and Movement Disorders, the event is open to patients and the public. Thanks to his fame, Fox has become the face of Parkinson's disease since publicly disclosing his diagnosis in 1998. On his new show, Parkinson's is front and center. Fox plays Mike Henry, a New York TV anchor who years earlier had quit his job to spend more time with his family after being diagnosed with Parkinson's. In the first episode, Fox decides to re-enter the workforce and get back Michael J. Fox as Mike Henry. (Photo by: Eric Liebowitz/NBC) In a video posted on NBC.com, Fox addressed people who have asked him how he could make fun of the disease. "We're not making fun of Parkinson's; we're examining a life, a life that has Parkinson's and just how one guy deals with it, one guy's experience with it," Fox said. "And my experience is to deal with things through humor. … Continue reading

Posted in Parkinson's Treatment | Comments Off on At St. Paul hospital, 'Michael J. Fox Show' premiere a reason to gather

Little Freya Hunter, 3, who has cerebral palsy and epilepsy battles for life after contracting salmonella in hospital

Posted: Published on September 25th, 2013

25 Sep 2013 07:51 DISTRAUGHT mum, Carolynne Hunter believes that the seriously ill tot caught the potentially fatal bug during treatment at Edinburgh's Royal Hospital for Sick Children. Daily Record A SERIOUSLY ill child is fighting for her life after contracting salmonella food poisoning in hospital. Three-year-old Freya Hunter, who needs to be fed through a tube, caught the killer bug during treatment. Mum Carolynne Hunter believes her daughter got the bug while being fed milk and water through the tube in the hospitals high dependency unit. She was told Edinburghs Royal Hospital for Sick Children had withdrawn feeding tubes and sterile milk to be tested as part of the infection probe. Last night, NHS Lothian confirmed a tube-fed patient had contracted salmonella and that everything was being done to prevent the spread of infection. Freya, who has cerebral palsy, epilepsy, spinal curvature, blindness and cant speak or eat and has to be tube-fed, was rushed to hospital after going into respiratory arrest. The youngster, from Alva, Clackmannanshire, was already in a very fragile condition when she was diagnosed with salmonella last Tuesday. Visit link: Little Freya Hunter, 3, who has cerebral palsy and epilepsy battles for life after contracting … Continue reading

Posted in Cerebral Palsy Treatment | Comments Off on Little Freya Hunter, 3, who has cerebral palsy and epilepsy battles for life after contracting salmonella in hospital

Family Receive £3m after Doctors Mistakes Leave Child with Cerebral Palsy, Asons Comment

Posted: Published on September 25th, 2013

Bolton, UK (PRWEB UK) 25 September 2013 Approved by the Leeds District Registry, Ruby Curtis received the substantial payment for cerebral palsy compensation to help support her moving forward with the neurological condition, as reported by The Yorkshire Post (1). After being admitted to St James hospital in Leeds 2005, doctors failed to recognise that Lisa Curtis had suffered a ruptured uterus. This serious complication meant that Ruby was starved of oxygen during her birth, which lead to her developing the brain injury (1). Speaking on the condition, Suzanne Yates from Cerebral Palsy Solicitors, Asons, said: Having seen many cerebral palsy claims come through to Asons, we fully understand how serious the repercussions can be for failing to spot a ruptured uterus. Not only does it put the mother at harm, but as you can see in this case, it has forever affected the quality of life that Ruby will now experience. Ruby will now need assistance to help her with everyday living, and unfortunately this will come at a substantial cost. Filing for cerebral palsy compensation will be highly beneficial and rewarding to the quality of life that Ruby will now experience as she will be able to continue … Continue reading

Posted in Cerebral Palsy Treatment | Comments Off on Family Receive £3m after Doctors Mistakes Leave Child with Cerebral Palsy, Asons Comment

Has Your Plaintiffs' Mild Brain Injuries Gone Undetected? What the NFL Concussion Litigation means for PI

Posted: Published on September 25th, 2013

NEW YORK, Sept. 24, 2013 /PRNewswire/ --MDL No. 2323 the NFL Players' Concussion Litigation has reached settlement with a degree of controversy. The premise of liability and the extent to which the NFL owed its players a duty to warn amid now decades of private medical research, was likely one of the most difficult and publicized TBI litigations in recent years. While the league is positioned to carry on 'business as usual' this season, it is disappointing not to see the claims of the former NFL players tested at trial with a jury. (Logo: http://photos.prnewswire.com/prnh/20130912/NY77185LOGO ) The term "traumatic brain injury" (TBI) covers a wide range of severity. Less obvious and more difficult to diagnose and prove are mild traumatic brain injuries (mTBIs), characterized by short and mild interruptions of normal brain activity and no change to normal mental status after the injury commonly called concussions. An obvious risk to participants of the game of football and other contact sports, but sometimes a not so obvious a risk in personal injury cases. Attorneys well versed in MVA litigation have made this consideration for years in their cases, but client intake for other case types should also look for signs of … Continue reading

Posted in Brain Injury Treatment | Comments Off on Has Your Plaintiffs' Mild Brain Injuries Gone Undetected? What the NFL Concussion Litigation means for PI

Dextrose gel could treat hypoglycemia in newborns

Posted: Published on September 25th, 2013

Featured Article Academic Journal Main Category: Pregnancy / Obstetrics Also Included In: Pediatrics / Children's Health Article Date: 25 Sep 2013 - 0:00 PDT Current ratings for: Dextrose gel could treat hypoglycemia in newborns A new study suggests that dextrose gel should be used to treat low blood sugars in newborn babies (neonatal-hypoglycemia) - a common and preventable cause of brain damage. Dextrose gel is an oral glucose gel, already used as form of treatment for reversal of hypoglycemia in diabetics. But researchers from New Zealand say the gel could be a cheap, effective and easy-to-use treatment for hypoglycemic newborn infants. At present, treatment for late preterm and term babies suffering from hypoglycemia involves additional feeding and repeated blood tests in order to measure blood sugar levels. However, many babies are admitted to intensive care and given intravenous glucose as a result of continuous low blood sugar levels. According to the Yale School of Medicine, around 1 in 3 newborn babies suffer from hypoglycemia. Newborns are at higher risk of the condition if the mother is diabetic, if they are small for their gestational age, or if they are growth-restricted, preterm or born under significant stress. Severe or prolonged hypoglycemia … Continue reading

Posted in Brain Injury Treatment | Comments Off on Dextrose gel could treat hypoglycemia in newborns

Strechforlife and Neurological Wellness Center Enter a Strategic Alliance to Facilitate the Expedient Recovery of …

Posted: Published on September 25th, 2013

(PRWEB) September 25, 2013 Since 2009, Stretch for Life has been enabling persons with stroke and traumatic brain injury (TBI) to regain feeling and function. The process involves full body stretching, massage, acupressure, strength training coupled with mental focus, breathing and visualization to eliminate spasticity and restore feeling and muscle function. The procedure is effective even years after a stroke or TBI. Once the habitually tight muscles have been coaxed into relaxing, the relaxation is permanent. The process begins as a series of treatments to relax the tight muscles and continues as a relearning to use the atrophied muscles. Lastly, the procedure involves exercises to restore strength and coordination. "By pretreating a client with perispinally administered etanercept (Enbrel), we vastly speed up the entire process and obtain results that would not be possible without the Enbrel," stated Phillip Koss developer of http://www.strechforlife.com. For example, an individual with stroke who is completely unable to walk and confined to a wheelchair could, after a series of daily treatments over several months, walk with a walker or even crutches. When such an individual is pretreated with perispinally administered Enbrel, the treatment is shortened from several months to a few weeks and the individual … Continue reading

Posted in Brain Injury Treatment | Comments Off on Strechforlife and Neurological Wellness Center Enter a Strategic Alliance to Facilitate the Expedient Recovery of …

Time to liberate ‘liberation’ therapy from MS

Posted: Published on September 25th, 2013

Here at Maclean's, we appreciate the written word. And we appreciate you, the reader. We are always looking for ways to create a better user experience for you and wanted to try out a new functionality that provides you with a reading experience in which the words and fonts take centre stage. We believe you'll appreciate the clean, white layout as you read our feature articles. But we don't want to force it on you and it's completely optional. Click "View in Clean Reading Mode" on any article if you want to try it out. Once there, you can click "Go back to regular view" at the top or bottom of the article to return to the regular layout. Last weeks cancellation of a clinical trial in Albany, N.Y., researching treatment of CCSVI is a big setback for those trying to glean scientific insight into whether venous angioplasty mitigates multiple sclerosis (MS) symptoms in people with MS who have obstructed venous flow. Its very bad news for the Saskatchewan government, which allocated $2.2 million to fund the trial and recruited volunteersto travel to the U.S. And it is a major blow for those whod taken part in the trial or … Continue reading

Posted in MS Treatment | Comments Off on Time to liberate ‘liberation’ therapy from MS

Data at ECTRIMS to confirm Novartis' Gilenya® long-term efficacy on reducing brain volume loss and real-world relapse …

Posted: Published on September 25th, 2013

New four-year data will show continued Gilenya treatment reduced brain volume loss in MS patients compared to delaying treatment with Gilenya by two years Data will strengthen the link between brain volume loss and disability progression, highlighting the importance of reducing brain volume loss in patients with MS Real-world patient data will confirm superiority of Gilenya compared to standard therapies (interferon and glatiramer acetate) in reducing MS relapse rates Basel, September 25, 2013 - New data showing the benefits of Gilenya (fingolimod) on patient outcomes in multiple sclerosis (MS) will be presented at the 29th Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS) in Copenhagen, Denmark, adding to the growing evidence base for Gilenya in both clinical trial and real-world settings. New four-year data from the pivotal FREEDOMS and FREEDOMS extension studies plus a separate analysis of three studies (FREEDOMS, FREEDOMS II and TRANSFORMS) will show the benefits of continued Gilenya treatment on brain volume loss compared to delayed treatment of two years. These data will reinforce what we know about the correlation between brain volume loss and disability, underlining the need for effectively addressing brain volume loss in patients with MS. Data from international … Continue reading

Posted in MS Treatment | Comments Off on Data at ECTRIMS to confirm Novartis' Gilenya® long-term efficacy on reducing brain volume loss and real-world relapse …

Low Testosterone May Be Linked to Heart Problems

Posted: Published on September 25th, 2013

Released: 9/20/2013 2:00 PM EDT Embargo expired: 9/24/2013 1:00 PM EDT Source Newsroom: Endocrine Society Newswise Chevy Chase, MDMen who have low testosterone levels may have a slightly elevated risk of developing or dying from heart disease, according to a recent study accepted for publication in The Endocrine Societys Journal of Clinical Endocrinology & Metabolism (JCEM). Testosterone is a key male sex hormone that helps maintain sex drive, sperm production and bone health. Over time, low testosterone may contribute to an increase in body fat, loss of body hair and muscle bulk. When we reviewed the existing research into testosterone and cardiovascular disease, a growing body of evidence suggested a modest connection between the two. A specific pathogenesis did not come forward, but perhaps less frequently investigated events may play a role, such as thrombosis where a blood clot develops in the circulatory system or arrhythmia, where there is a problem with the heart beat or rate, said the studys lead author, Johannes Ruige, MD, PhD, of Ghent University Hospital in Belgium. Based on current findings, though, we cannot rule out that low testosterone and heart disease both result from poor overall health. Treating low testosterone with replacement therapy did … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on Low Testosterone May Be Linked to Heart Problems

Disease-specific human embryonic stem cell lines from King's College London placed on NIH Registry

Posted: Published on September 25th, 2013

Javascript is currently disabled in your web browser. For full site functionality, it is necessary to enable Javascript. In order to enable it, please see these instructions. 18 hours ago This image shows a hES cell colony immunostained for pluripotency markers nanog (red) and TRA-1-60 (green). Credit: Dusko Ilic, King's College London Scientists from King's College London have announced that 16 human embryonic stem (hES) cell lines have been approved by the US National Institutes of Health (NIH) and placed on their Stem Cell Registry, making them freely available for federally-funded research in the USA. The stem cell lines, which carry genes for a variety of hereditary disorders such as Huntington's disease, spinal muscular dystrophy and cystic fibrosis, are considered to be ideal research tools for designing models to understand disease progression, and ultimately in helping scientists develop new treatments for patients. King's is now one of the five biggest providers of disease-specific human embryonic stem cells lines on the NIH Registry, and the largest from the UK. The development is a significant milestone for King's and keeps the university at the forefront of global research into regenerative medicine. Embryonic stem cell lines are grown from frozen embryos donated by … Continue reading

Posted in Stem Cell Research | Comments Off on Disease-specific human embryonic stem cell lines from King's College London placed on NIH Registry

Page 4,889«..1020..4,8884,8894,8904,891..4,9004,910..»